» Articles » PMID: 31202519

Long Non-coding RNAs in Retinoblastoma

Overview
Specialty Pathology
Date 2019 Jun 17
PMID 31202519
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoblastoma represents 3% of all childhood cancers and is the most common intraocular malignant tumor with a highly aggressive and metastatic phenotype. While recent genetic and epigenetic studies have reported new insights into the mechanism of retinoblastoma development, the involvement of regulatory non-coding RNAs remains unclear. Long non-coding RNAs (lncRNAs) are a group of endogenous non-protein-coding RNAs with the capacity to regulate gene expression at multiple levels. Recent evidence has shown that lncRNAs can regulate many cellular processes, such as cell proliferation, differentiation, migration, and invasion. Several lncRNAs, including BANCR, AFAP1-AS1, NEAT1, XIST, ANRIL, PlncRNA-1, HOTAIR, PANDAR, DANCR, and THOR, promote the progression and metastasis of retinoblastoma. However, some lncRNAs, such as MEG3, MT1JP, and H19, play a tumor suppressive role. Our review summarizes the functional role of lncRNAs in retinoblastoma and their potential clinical applications for diagnosis, prognosis, and treatment.

Citing Articles

HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives.

Nazari M, Babakhanzadeh E, Mollazadeh A, Ahmadzade M, Mohammadi Soleimani E, Hajimaqsoudi E Cancer Cell Int. 2024; 24(1):415.

PMID: 39702144 PMC: 11660992. DOI: 10.1186/s12935-024-03612-x.


Retinoblastoma: An update on genetic origin, classification, conventional to next-generation treatment strategies.

Pareek A, Kumar D, Pareek A, Gupta M, Jeandet P, Ratan Y Heliyon. 2024; 10(12):e32844.

PMID: 38975183 PMC: 11226919. DOI: 10.1016/j.heliyon.2024.e32844.


LncRNA LOXL1-AS1 promotes proliferation and invasion and inhibits apoptosis in retinoblastoma by regulating the MAPK signaling pathway.

Wu W, Zhang Y, Xu C, Yang H, Liu S, Huang G Mol Cell Biochem. 2023; 479(4):1011-1022.

PMID: 37273040 DOI: 10.1007/s11010-023-04774-4.


KCNQ1OT1 promotes retinoblastoma progression by targeting miR-339-3p that suppresses KIF23.

Tang W, Zhang L, Li J, Guan Y Int Ophthalmol. 2023; 43(7):2419-2432.

PMID: 37198502 DOI: 10.1007/s10792-023-02641-1.


Review: New horizons in retinoblastoma treatment: an updated review article.

Azimi F, Mirshahi R, Naseripour M Mol Vis. 2022; 28:130-146.

PMID: 36034735 PMC: 9352364.